JPM25: Emergent secures licensing deal for opioid overdose spray amid recovery plan

After its sudden rise and precipitous fall during the COVID-19 pandemic, Emergent BioSolutions is taking measured steps as it attempts to reestablish its unique role as a drug developer combating urgent public health threats.